



|                                                      |  Low (N=80)  | Mild (N=54)  |  High (N=79)  | Total (N=213) | p value|
|:-----------------------------------------------------|:------------:|:------------:|:-------------:|:-------------:|-------:|
|**Avaliable vaccine type**                            |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;wP                                  | 65 (81.25%)  | 31 (57.41%)  |  27 (34.18%)  | 123 (57.75%)  |        |
|&nbsp;&nbsp;&nbsp;aP                                  | 12 (15.00%)  | 18 (33.33%)  |  46 (58.23%)  |  76 (35.68%)  |        |
|&nbsp;&nbsp;&nbsp;Both                                |  3 (3.75%)   |  5 (9.26%)   |   6 (7.59%)   |  14 (6.57%)   |        |
|**Coverage of DTP1 (%)**                              |              |              |               |               |   0.067|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      9       |      6       |       3       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    93.00     |    95.50     |     97.00     |     95.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 84.50, 98.50 | 82.50, 99.00 | 91.75, 98.00  | 87.00, 98.00  |        |
|**Coverage of DTP3 (%)**                              |              |              |               |               |   0.047|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      9       |      6       |       3       |      18       |        |
|&nbsp;&nbsp;&nbsp;Median                              |    88.00     |    86.50     |     92.00     |     91.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 76.50, 97.00 | 75.75, 97.25 | 85.00, 96.00  | 78.50, 97.00  |        |
|**General vaccine recommendation**                    |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |     4.00     |     4.50     |     5.00      |     4.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  3.00, 5.00  |  3.00, 5.00  |  4.00, 5.00   |  3.00, 5.00   |        |
|**General vaccine recommendation for toddlers, -3yr** |              |              |               |               |   0.064|
|&nbsp;&nbsp;&nbsp;Median                              |     3.00     |     4.00     |     4.00      |     4.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  3.00, 4.00  |  3.00, 4.00  |  3.00, 4.00   |  3.00, 4.00   |        |
|**General vaccine recommendation for children, 3+yr** |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |     0.00     |     0.50     |     1.00      |     1.00      |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              |  0.00, 1.00  |  0.00, 2.00  |  1.00, 2.00   |  0.00, 2.00   |        |
|**Time of last shot (months)**                        |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;Median                              |    18.00     |    33.75     |     72.00     |     48.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 3.22, 54.00  | 3.33, 120.00 | 24.00, 150.00 | 12.00, 120.00 |        |
|**Vaccine recommendation for pregnant**               |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;No                                  | 75 (93.75%)  | 46 (85.19%)  |  47 (59.49%)  | 168 (78.87%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  5 (6.25%)   |  8 (14.81%)  |  32 (40.51%)  |  45 (21.13%)  |        |
|**Vaccine recommendation for adults**                 |              |              |               |               |   0.034|
|&nbsp;&nbsp;&nbsp;No                                  | 78 (97.50%)  | 46 (85.19%)  |  71 (89.87%)  | 195 (91.55%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  2 (2.50%)   |  8 (14.81%)  |  8 (10.13%)   |  18 (8.45%)   |        |
|**Vaccine recommendation for risk groups**            |              |              |               |               | < 0.001|
|&nbsp;&nbsp;&nbsp;No                                  | 76 (95.00%)  | 48 (88.89%)  |  59 (74.68%)  | 183 (85.92%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  4 (5.00%)   |  6 (11.11%)  |  20 (25.32%)  |  30 (14.08%)  |        |
|**Pertussis status in 2022/2023**                     |              |              |               |               |   0.018|
|&nbsp;&nbsp;&nbsp;N-Miss                              |      20      |      3       |       6       |      29       |        |
|&nbsp;&nbsp;&nbsp;Low                                 | 42 (70.00%)  | 23 (45.10%)  |  52 (71.23%)  | 117 (63.59%)  |        |
|&nbsp;&nbsp;&nbsp;Normal                              |  7 (11.67%)  | 10 (19.61%)  |  9 (12.33%)   |  26 (14.13%)  |        |
|&nbsp;&nbsp;&nbsp;High                                |  0 (0.00%)   |  5 (9.80%)   |   5 (6.85%)   |  10 (5.43%)   |        |
|&nbsp;&nbsp;&nbsp;Resurgence                          | 11 (18.33%)  | 13 (25.49%)  |   7 (9.59%)   |  31 (16.85%)  |        |
